Boothbay Fund Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,200
Closed -$779K 2159
2025
Q3
$779K Buy
+4,200
New +$720K 0.01% 941
2024
Q4
Sell
-26,300
Closed -$4.26M 1723
2024
Q3
$4.26M Buy
26,300
+8,300
+46% +$1.32M 0.1% 298
2024
Q2
$2.63M Hold
18,000
0.06% 419
2024
Q1
$2.85M Buy
+18,000
New +$2.87M 0.05% 392
2023
Q1
Sell
-61,300
Closed -$10.8M 2328
2022
Q4
$10.8M Buy
61,300
+55,200
+905% +$9.53M 0.25% 58
2022
Q3
$997K Buy
6,100
+3,200
+110% +$542K 0.02% 873
2022
Q2
$515K Sell
2,900
-9,000
-76% -$1.6M 0.01% 1160
2022
Q1
$2.11M Buy
+11,900
New +$2.02M 0.05% 565

Other funds holding JNJ

Boothbay Fund Management's JNJ Position: Q1 2026 in Review

Boothbay Fund Management reduced its Johnson & Johnson (JNJ) stake by 74% in Q1 2026, selling an estimated $878K and leaving 1,331 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

Boothbay Fund Management first reported a position in JNJ in Q1 2015 and has held it in 21 quarters since. The position peaked at $13.7M in Q3 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Boothbay Fund Management held 1,331 shares of Johnson & Johnson worth $325K as of Q1 2026.
  • Boothbay Fund Management sold 3,769 Johnson & Johnson shares in Q1 2026, an estimated $878K.
  • Johnson & Johnson made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1573 holding.
  • Boothbay Fund Management first reported a position in Johnson & Johnson in Q1 2015 and has held it in 21 quarters since.
  • Boothbay Fund Management's Johnson & Johnson position peaked at $13.7M in Q3 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.